// App-Quantinova.ai

44 : Genome‐wide association study (GWAS) to identify genetic risk factors that increase susceptibility to anti‐tuberculosis drug‐induced liver injury (ATDILI).

Researchers

Presenter

  • Paola Nicoletti

Principal Investigators

  • Harshad Devarbhavi

  • Ashish Goel

  • C.E. Eapen

  • Radha Venkatesan

  • Jane I. Grove

  • Ann K. Daly

  • Guruprasad P. Aithal

Medical Centers

  • Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, United Kingdom

  • Nottingham Digestive Diseases Centre, University of Nottingham, Nottingham, United Kingdom

  • Department of Genetics and Genomic Sciences Icahn School of Medicine at Mount Sinai, New York, NY

  • St John's Medical College Hospital, Department of Gastroenterology, Bangalore, India

  • Christian Med Coll and Hosp, Vellore, India

  • Molecular Genetics, Madras Diabetes Research Foundation, Chennai, , India

  • Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom

Locations

  • United Kingdom

  • United States

  • India

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Tuberculosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved